Stock listing

NASDAQ:HRMY Harmony Biosciences Holdings, Inc. Stock

Home listing (NASDAQ) of Harmony Biosciences Holdings, Inc.

Follow Harmony Biosciences Holdings, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:HRMY

$37.95 USD -0.32 (-0.8%)

Close on Oct 16, 2026

Since Jul 6, 2026 +2.5% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
$37.85 – $39.00 USDOct 16, 2026
Volume
892,251 sharesOct 16, 2026
Market value
$2.21B USDAt the close on Oct 16, 2026 · price × 58.24M shares outstanding
Harmony Biosciences Holdings, Inc. logo
Ticker
NASDAQ:HRMY
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Harmony Biosciences Holdings (NASDAQ:HRMY) Q2 2026 Earnings Call

    Tue, Aug 04, 2026 · 5:00 PM ET

    Watch Transcript

  • Harmony Biosciences Holdings (NASDAQ:HRMY) Q1 2026 Earnings Call

    Thu, May 07, 2026 · 8:30 AM ET

    Watch Transcript

  • Harmony Biosciences Holdings (NASDAQ:HRMY) Q4 2025 Earnings Call

    Tue, Feb 24, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

Harmony Biosciences Announces Planned CEO Transition to Support Next Phase of Growth

Oct 12, 2026

Harmony Biosciences Announces Poster Presentation at the 17th European Narcolepsy Days

Oct 1, 2026

Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress

Sep 3, 2026

Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference

Aug 27, 2026

Harmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class Profile

Aug 4, 2026

Harmony Biosciences To Report Second Quarter 2026 Financial Results On August 4, 2026

Jul 21, 2026

Harmony Biosciences Preannounces Record Quarterly Revenue for Q2 2026, Reaffirms Full-Year 2026 Revenue Guidance, and Announces CFO Transition

Jul 16, 2026

Harmony Biosciences Announces Poster Presentations at 2026 SLEEP Annual Meeting

Jun 11, 2026

Harmony Biosciences Reports Q1 Financial Results and Confirms 2026 Net Revenue Guidance of Over $1 Billion; Reinforces 2026 Strategic Priorities

May 7, 2026

Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026

Apr 23, 2026

All Harmony Biosciences Holdings, Inc. news

Decks

Harmony Biosciences Holdings, Inc. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
26 in the last 12 months · 172 in all · newest Oct 12, 2026 · oldest 2020
Calls
23 calls with a replay · 23 with a transcript · latest Aug 4, 2026
Decks
28 decks · latest Aug 4, 2026

Where Harmony Biosciences Holdings, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:HRMY · Home listing · This pageNASDAQUnited StatesUSD
BMV:HRMYBMVMexicoMXN
BIVA:HRMYBIVAMexicoMXN
Stuttgart:60HStuttgartGermanyEUR
BOATS:HRMYBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Harmony Biosciences Holdings, Inc.